Literature DB >> 31352578

First-in-human 18F-SiFAlin-TATE PET/CT for NET imaging and theranostics.

Harun Ilhan1, A Todica2, S Lindner2, G Boening2, A Gosewisch2, C Wängler3, B Wängler4, R Schirrmacher5, P Bartenstein2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31352578     DOI： 10.1007/s00259-019-04448-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  3 in total

1.  ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site.

Authors:  M Pavel; D O'Toole; F Costa; J Capdevila; D Gross; R Kianmanesh; E Krenning; U Knigge; R Salazar; U-F Pape; K Öberg
Journal:  Neuroendocrinology       Date:  2016-01-05       Impact factor: 4.914

2.  In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.

Authors:  Sabrina Niedermoser; Joshua Chin; Carmen Wängler; Alexey Kostikov; Vadim Bernard-Gauthier; Nils Vogler; Jean-Paul Soucy; Alexander J McEwan; Ralf Schirrmacher; Björn Wängler
Journal:  J Nucl Med       Date:  2015-05-14       Impact factor: 10.057

3.  The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours.

Authors:  L Bodei; J Mueller-Brand; R P Baum; M E Pavel; D Hörsch; M S O'Dorisio; T M O'Dorisio; T M O'Dorisiol; J R Howe; M Cremonesi; D J Kwekkeboom; John J Zaknun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05       Impact factor: 9.236
  3 in total
  8 in total

1.  High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT.

Authors:  Rudolf A Werner; Thorsten Derlin; Steven P Rowe; Lena Bundschuh; Gabriel T Sheikh; Martin G Pomper; Sebastian Schulz; Takahiro Higuchi; Andreas K Buck; Frank M Bengel; Ralph A Bundschuh; Constantin Lapa
Journal:  J Nucl Med       Date:  2020-08-28       Impact factor: 10.057

Review 2.  [Theranostics and hybrid imaging for somatostatin receptor-expressing tumors].

Authors:  Rudolf A Werner; Frank M Bengel; Thorsten Derlin
Journal:  Radiologe       Date:  2020-05       Impact factor: 0.635

3.  Radiosynthesis of [18F]SiFAlin-TATE for clinical neuroendocrine tumor positron emission tomography.

Authors:  Simon Lindner; Carmen Wängler; Björn Wängler; Ralf Schirrmacher; Justin J Bailey; Klaus Jurkschat; Peter Bartenstein
Journal:  Nat Protoc       Date:  2020-11-23       Impact factor: 13.491

4.  The battle on time, money and precision: Da[18F] id vs. [68Ga]liath.

Authors:  Sabri Sahnoun; Patrick Conen; Felix M Mottaghy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-12       Impact factor: 9.236

5.  Development of [18F]AmBF3 Tetrazine for Radiolabeling of Peptides: Preclinical Evaluation and PET Imaging of [18F]AmBF3-PEG7-Tyr3-Octreotide in an AR42J Pancreatic Carcinoma Model.

Authors:  Sofia Otaru; Andreas Paulus; Surachet Imlimthan; Iida Kuurne; Helena Virtanen; Heidi Liljenbäck; Tuula Tolvanen; Tatsiana Auchynnikava; Anne Roivainen; Kerttuli Helariutta; Mirkka Sarparanta; Anu J Airaksinen
Journal:  Bioconjug Chem       Date:  2022-06-16       Impact factor: 6.069

6.  Metabolism of a Bioorthogonal PET Tracer Candidate [19F/18F]SiFA-Tetrazine in Mouse Liver Microsomes: Biotransformation Pathways and Defluorination Investigated by UHPLC-HRMS.

Authors:  Sofia Otaru; Hanna Niemikoski; Mirkka Sarparanta; Anu J Airaksinen
Journal:  Mol Pharm       Date:  2020-07-01       Impact factor: 4.939

7.  Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours.

Authors:  Leonie Beyer; Astrid Gosewisch; Simon Lindner; Friederike Völter; Lena M Mittlmeier; Reinhold Tiling; Matthias Brendel; Clemens C Cyran; Marcus Unterrainer; Johannes Rübenthaler; Christoph J Auernhammer; Christine Spitzweg; Guido Böning; F J Gildehaus; Klaus Jurkschat; Carmen Wängler; Björn Wängler; Ralf Schirrmacher; Vera Wenter; Andrei Todica; Peter Bartenstein; Harun Ilhan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04-29       Impact factor: 9.236

Review 8.  New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms.

Authors:  Emilia Fortunati; Giulia Argalia; Lucia Zanoni; Stefano Fanti; Valentina Ambrosini
Journal:  Curr Treat Options Oncol       Date:  2022-03-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.